Sparrow Pharmaceuticals, Inc.

New Filing
CIK: 0001786949·Pharmaceuticals·DELAWARE·Filed: Nov 15, 2019
Total Offering

$8,000,000

Amount Sold

$270,000

Investors

10

First Sale

Aug 21, 2018

Offering Details

Type
Debt, Option to Acquire
Exemptions
Rule 506(b)
Entity Type
Corporation
Non-Accredited Investors
No

Related Persons

NameRole
David Aaron Katz
Related Person

Company

Sparrow Pharmaceuticals, Inc.

4640 SW MACADAM AVE

PORTLAND, OR, 97239

312-752-8446

SEC Filing

0001786949-19-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
Sparrow Pharmaceuticals, Inc. Form D Filing — $8,000,000 | FilingFlow